Singular Health Group (ASX:SHG) Risk Assessment


ASX:SHG Singular Health Group Ltd ASX:SHG
30 GF Score
Price A$0.21
GF Value A$0.11
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Singular Health Group Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Singular Health Group is: No Data: Cannot be evaluated.

Singular Health Group  (ASX:SHG) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Singular Health Group Risk Assessment Related Terms

ASX:SHG vs VEEV, BTSG, TEM: Risk Assessment Comparison

For the Health Information Services subindustry, Singular Health Group's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Singular Health Group Risk Assessment vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singular Health Group's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Singular Health Group's Risk Assessment falls into.


ASX:SHG
30GF Score
Singular Health Group Ltd ASX:SHG
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Singular Health Group (ASX:SHG) Overvalued in 2026?

Based on GuruFocus' analysis, Singular Health Group stock appears to be overvalued. The current stock price of A$0.21 is trading 90.9% above its estimated GF Value™ of A$0.11. GuruFocus considers Singular Health Group to be Significantly Overvalued.

Key valuation signals for ASX:SHG:

  • Risk Assessment:
  • GF Value™: A$0.11 vs. price of A$0.21 (90.9% above fair value)
  • GF Score™: 30/100 with 2 warning signs

No single metric tells the full story. See the ASX:SHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Singular Health Group Business Description

Address E3 and E4, 661 Newcastle Street, Leederville, WA, AUS, 6007
Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.
30GF Score

Get the complete analysis for ASX:SHG

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.21
Price
A$0.11
GF Value